Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)


Echocardiography Guided Cardiac Resynchronization Therapy (EchoCRT)




The EchoCRT trial evaluates the effects of Cardiac Resynchronization Therapy (CRT) on mortality and morbidity of subjects with heart failure due to left ventricular systolic dysfunction, already receiving optimized HF medication, with a narrow QRS width (< 130 ms) and echocardiographic evidence of ventricular dyssynchrony.

Study Status: Terminated


Condition Intervention Phase
Heart Failure
Ventricular Dyssynchrony
Device: Implantable Cardioverter Defibrillator with Cardiac Resynchronization Therapy (BIOTRONIK Lumax HF-T CRT-D) Phase 2/Phase 3

Verified by Biotronik, Inc. April, 2013

Sponsored by: Biotronik, Inc.
Information provided by: Biotronik, Inc. identifier: NCT00683696

Study Type: Interventional

Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Cleveland Clinic
Cleveland, Ohio 44145
United States

Frank Ruschitzka, MD., Study Chair
Johannes Holzmeister, MD., Study Chair
William Abraham, MD., Principal Investigator
Jagmeet Singh, MD., Principal Investigator

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit
  Information obtained from on
Link to the current record.

Cleveland Clinic Mobile Site